Phytochemical Name : Eupalinolide O

Properties Information
PhytoCAT-ID PhytoCAT-145
Phytochemical name or plant extracts Eupalinolide O
PMID 27666560
Literature evidence Here, we demonstrated that Eupalinolide O (EO), a novel sesquiterpene lactone isolated from Eupatorium lindleyanum DC., showed significant anticancer activity against human MDA-MB-468 breast cancer cells.
IUPAC name [(3aR,4R,6E,9S,10E,11aR)-9-acetyloxy-6-formyl-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] (E)-4-hydroxy-2-methylbut-2-enoate
Phytochemicals’ class or type of plant extracts Sesquiterpene lactone
Source of phytochemicals or plant Extracts Eupatorium lindleyanum
Geographical availability Amur, China North-Central, China South-Central, China Southeast, Hainan, Inner Mongolia, Japan, Khabarovsk, Korea, Manchuria, Myanmar, Nansei-shoto, Philippines, Primorye, Qinghai, Taiwan, Tibet, Vietnam
Plant parts NA
Other cancers Breast cancer
Target gene or protein Cyclin B1, cdc2
Gene or Protein evidence The expression of cell cycle-related proteins (cyclin B1 and cdc2) was significantly decreased.
Target pathways Akt pathway
IC50 NA
Potency Collectively, EO suppressed the growth of the MDA-MB‑468 cells possibly by cell cycle arrest in the G2/M phase and the induction of caspase-dependent apoptosis. These results suggest that EO is a promising natural compound for breast cancer therapy.
Cell line/ mice model MDA-MB-468
Additional information  Further study demonstrated that EO induced apoptotic cell death in the MDA-MB-468 cells through the activation of caspases. The effect of EO on the induction of apoptosis was significantly prevented by the treatment of pan-caspase inhibitor Z-VAD-FMK. We also found that EO treatment resulted in cell cycle arrest in the G2/M phase.
PubChem ID 154809464
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:206259-1
Safety NA